Trial Profile
Phase 3, Placebo Controlled, Randomized, Double-blinded, Nonsteroidal Antiinflammatory Drug add-on Clinical Trial of Mono-phase Low Dose Oral Contraceptive Pill for Treatment of Primary Dysmenorrhea.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Estradiol/norethisterone (Primary)
- Indications Dysmenorrhoea
- Focus Therapeutic Use
- Sponsors Nobelpharma
- 21 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 May 2009 Actual patient number (113) added as reported by ClinicalTrials.gov.
- 06 May 2009 Actual initiation date (Sep 2008) added as reported by ClinicalTrials.gov.